Vaccine, hepatitis A + hepatitis B


Thông tin thuốc gốc
Chỉ định và Liều dùng
Intramuscular
Active immunisation against hepatitis A, Active immunisation against hepatitis B
Adult: Available preparation:
Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg. Primary immunisation: 1 mL for 3 doses given at 0-, 1-, and 6-months. Alternatively, in exceptional circumstances, an accelerated dose of 1 mL for 3 doses, may be given on days 0, 7, and 21 followed by a booster at 12 months. May be given via SC administration in patients with bleeding disorders.
Child: Available preparations:
Each 0.5 mL inj contains hepatitis A virus (inactivated) 360 ELISA U and recombinant hepatitis B surface antigen 10 mcg
1-15 years Primary immunisation: 0.5 mL for 3 doses, given at 0, 1, and 6 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.

Each 1 mL inj contains hepatitis A virus (inactivated) 720 ELISA U and recombinant hepatitis B surface antigen 20 mcg.
1-15 years Primary immunisation: 1 mL for 2 doses given at 0 and between 6-12 months; ≥16 years Same as adult dose. May be given via SC administration in patients with bleeding disorders.
Chống chỉ định
Hypersensitivity. Acute severe febrile illness.
Thận trọng
Patient with immunodeficiency or receiving immunosuppressive therapy or on haemodialysis, thrombocytopenia, bleeding disorder. Obese patients (BMI ≥130%). Not intended for postexposure prophylaxis. Children. Pregnancy and lactation.
Phản ứng phụ
Significant: Syncope, bleeding/haematoma.
Gastrointestinal disorders: Nausea, vomiting, diarrhoea, abdominal pain.
General disorders and administration site conditions: Fatigue, malaise, fever, irritability, inj site reaction (e.g. pain, swelling, redness, bruising, pruritus).
Metabolism and nutrition disorders: Appetite loss.
Musculoskeletal and connective tissue disorders: Myalgia.
Nervous system disorders: Headache, drowsiness.
Respiratory, thoracic and mediastinal disorder: Upper respiratory tract infection.
Potentially Fatal: Rarely, anaphylactic reactions.
MonitoringParameters
Monitor for syncope for 15 minutes following administration. Maintain supine or Trendelenburg position to establish adequate cerebral perfusion for seizure-like activity associated with syncope.
Tương tác
Reduced immune response to vaccination with immunosuppressants. Risk of bleeding with anticoagulants.
Tác dụng
Description: Vaccine, hepatitis A + hepatitis B is a combined vaccine from purified, inactivated hepatitis A virus (HAV) and recombinant hepatitis B surface antigen (HBsAg). It stimulates the production of HAV immunoglobulin and antibodies and anti-HBs antibodies that neutralizes the pathogenic properties of HAV and hepatitis B virus (HBV).
Onset: Within 2-4 weeks.
Duration: 15 years.
Bảo quản
Store between 2-8°C. Do not freeze. Protect from light.
Any unused portions should be disposed of in accordance with local requirements.
Phân loại ATC
J07BC - Hepatitis vaccines ; Used for active immunizations.
References
Anon. Hepatitis A and Hepatitis B Recombinant Vaccine. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. https://online.lexi.com. Accessed 08/08/2017.

Anon. Hepatitis A Virus Vaccine Inactivated. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 08/08/2017.

Anon. Hepatitis B Vaccine. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. https://www.ahfscdi.com. Accessed 22/08/2018.

Buckingham R (ed). Hepatitis A and B Vaccines. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 08/08/2017.

Twinrix Vaccine Injection, Suspension (GlaxoSmithKline Biologicals SA). DailyMed. Source: U.S. National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/. Accessed 22/08/2018.

Thông báo miễn trừ trách nhiệm: Thông tin này được MIMS biên soạn một cách độc lập dựa trên thông tin của Vaccine, hepatitis A + hepatitis B từ nhiều nguồn tài liệu tham khảo và được cung cấp chỉ cho mục đích tham khảo. Việc sử dụng điều trị và thông tin kê toa có thể khác nhau giữa các quốc gia. Vui lòng tham khảo thông tin sản phẩm trong MIMS để biết thông tin kê toa cụ thể đã qua phê duyệt ở quốc gia đó. Mặc dù đã rất nỗ lực để đảm bảo nội dung được chính xác nhưng MIMS sẽ không chịu trách nhiệm hoặc nghĩa vụ pháp lý cho bất kỳ yêu cầu bồi thường hay thiệt hại nào phát sinh do việc sử dụng hoặc sử dụng sai các thông tin ở đây, về nội dung thông tin hoặc về sự thiếu sót thông tin, hoặc về thông tin khác. © 2021 MIMS. Bản quyền thuộc về MIMS. Phát triển bởi MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in